BEDINI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 4.431
AS - Asia 3.757
EU - Europa 3.422
AF - Africa 441
SA - Sud America 234
Continente sconosciuto - Info sul continente non disponibili 202
OC - Oceania 3
Totale 12.490
Nazione #
US - Stati Uniti d'America 4.363
SG - Singapore 1.133
CN - Cina 1.028
IT - Italia 854
GB - Regno Unito 810
VN - Vietnam 795
DE - Germania 417
SE - Svezia 272
HK - Hong Kong 233
FR - Francia 209
IN - India 195
RU - Federazione Russa 190
BR - Brasile 164
TG - Togo 163
UA - Ucraina 145
IE - Irlanda 120
CI - Costa d'Avorio 85
BG - Bulgaria 84
JP - Giappone 82
NG - Nigeria 81
ZA - Sudafrica 78
EE - Estonia 63
FI - Finlandia 54
NL - Olanda 54
JO - Giordania 43
BD - Bangladesh 34
CA - Canada 33
KR - Corea 29
PH - Filippine 28
AR - Argentina 27
CH - Svizzera 27
ID - Indonesia 26
TR - Turchia 22
ES - Italia 21
HR - Croazia 21
MX - Messico 21
SC - Seychelles 20
IR - Iran 15
BE - Belgio 14
TH - Thailandia 14
IQ - Iraq 13
PK - Pakistan 13
PL - Polonia 12
GR - Grecia 11
AT - Austria 10
CL - Cile 10
CO - Colombia 9
LB - Libano 8
UZ - Uzbekistan 8
LT - Lituania 7
TW - Taiwan 7
EC - Ecuador 6
PE - Perù 6
RO - Romania 6
KZ - Kazakistan 5
MA - Marocco 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
IL - Israele 4
LU - Lussemburgo 4
PY - Paraguay 4
SA - Arabia Saudita 4
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GY - Guiana 3
KE - Kenya 3
VE - Venezuela 3
AU - Australia 2
CY - Cipro 2
DK - Danimarca 2
NP - Nepal 2
RS - Serbia 2
SI - Slovenia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 12.289
Città #
Singapore 751
Southend 699
Ashburn 350
San Jose 348
Fairfield 340
Chandler 312
Santa Clara 310
Bologna 257
Hong Kong 222
Princeton 185
Ho Chi Minh City 163
Lomé 163
Wilmington 162
Hanoi 158
Beijing 156
Woodbridge 156
Seattle 145
Cambridge 141
Houston 137
Ann Arbor 127
Dublin 118
Dong Ket 102
Boardman 93
Nanjing 87
Jacksonville 86
Abidjan 85
Sofia 84
Abeokuta 81
Lauterbourg 80
Westminster 77
Padova 75
Tokyo 74
Milan 65
Los Angeles 57
Medford 50
Jinan 49
Berlin 48
Council Bluffs 46
Saint Petersburg 46
Hefei 45
Amman 43
Shenyang 43
Helsinki 41
New York 41
Frankfurt am Main 36
Buffalo 35
Redondo Beach 35
Dallas 34
Hebei 31
San Diego 31
Tianjin 30
Nanchang 29
Shanghai 26
Redmond 25
Changsha 24
Guangzhou 24
Haiphong 24
Munich 22
Mülheim 22
Bremen 20
Chicago 19
Seoul 19
Da Nang 18
Modena 18
Norwalk 17
London 16
Falls Church 15
Phoenix 15
São Paulo 15
Zhengzhou 15
Bern 14
Des Moines 14
Haikou 14
Yubileyny 14
Moscow 13
Nuremberg 13
Redwood City 13
Brussels 12
Hangzhou 12
Jakarta 12
Wuhan 12
Rimini 11
Shenzhen 11
Turin 11
Turku 11
Denver 10
Falkenstein 10
Hải Dương 10
Jiaxing 10
Mahé 10
Orem 10
Paris 10
Porto Alegre 10
Toronto 10
Biên Hòa 9
Istanbul 9
Ningbo 9
Parma 9
Rome 9
Taizhou 9
Totale 7.844
Nome #
Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration 278
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist 273
T cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional {micro}-opioid receptors. 259
Chitosan-based Polyelectrolyte Complexes for Nasal Drug Delivery 253
Ligand Based Approach to L-Type Calcium Channel by Imidazo[2,1-b]thiazole-1,4-Dihydropyridines: from Heart Activity to Brain Affinity 243
Nociceptin/orphanin FQ antagonizes lipopolysaccharide-stimulated proliferation, migration and inflammatory signaling in human glioblastoma U87 cells 237
Diphenidol-related diamines as novel muscarinic M4 receptor antagonists 221
DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs 221
Therapeutic Targeting of Eosinophil Adhesion and Accumulation in Allergic Conjunctivitis 218
REST is up-regulated by epidermal growth factor in HeLa cells and inhibits apoptosis by influencing histone H3 acetylation 214
Transcription factor REST negatively influences the protein kinase C-dependent up-regulation of human mu-opioid receptor gene transcription 209
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist 209
Antiangiogenic Effect of Dual/Selective α5β1/αvβ3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics 207
A novel family of minimalist opioid peptides deprived of the classic pharmacophores 207
Ac-D-Trp-PheNH2 AND Ac-D-Trp-Phe-GlyNH2 - A NEW CLASS OF UNUSUAL OPIOID PEPTIDES 205
Plasma nociceptin/orphanin FQ levels in response to the hyperventilation test in healthy subjects. 192
Imidazo[2,1-b]thiazole System: a Scaffold Endowing Dihydropyridines With Selective Cardiodepressant Activity 191
Investigation of the Interaction Between the Atypical Agonist c[YpwFG] and MOR 184
Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastine 184
The Inverse Type II β-Turn on D-Trp-Phe, a Pharmacophoric Motif for MOR Agonists. 182
Identification of c[D-Trp-Phe-β-Ala-β-Ala], the First κ-Opioid Receptor-Specific Negative Allosteric Modulator 181
DESIGN AND SYNTHESIS OF OPIOID PEPTIDE ANALOGUES AND MIMETICS 181
Plasma nociceptin/orphanin FQ levels rise after spontaneous episodes of angina, but not during induced myocardial ischemia 180
Opioid Activity Profiles of Oversimplified Peptides Lacking in the Protonable N-Terminus 178
Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist 178
A Blocking Group Scan Using a Spherical Organometallic Complex Identifies an Unprecedented Binding Mode with Potent Activity In Vitro and In Vivo for the Opioid Peptide Dermorphin 178
mu-opioid receptor (MOR) expression and opioid-mediated intracellular signalling are altered in glial cells exposed to TNF-alpha 169
Role of nociceptin/orphanin FQ in thermoregulation 167
Prodynorphin-derived peptides 166
A new generation of opioid peptidomimetics acting as central and/or peripheral analgesics 165
Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms 165
Versatile Picklocks to Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe- d -Pro-Phe-Trp] (CJ-15,208) 159
Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis 152
DETERMINATION OF THE BIOLOGICALLY ACTIVE STRUCTURE OF THE ATYPICAL MOR-LIGAND c[D-Asp-1-amide-beta-Ala-D-Trp-Phe] AND ANALOGUES BY NMR AND MOLECULAR DOCKING 151
Transcriptional activation of human mu-opioid receptor gene by insulin-like growth factor-I in neuronal cells is modulated by the transcription factor REST 151
Bioluminescence resonance energy transfer (BRET) to detect the interactions between kappa opioid receptor and non visual arrestins. 150
Renilla luciferase reporter assay to study 3'UTR-driven posttranscriptional regulations of OPRM1. 143
Development and characterization of novel EphB1 receptor antagonists. 143
Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes 141
Novel Antagonist targeting EphB1 receptor 136
Innovative opioid peptides and biased agonism: Novel avenues for more effective and safer analgesics to treat chronic pain 136
Interactions between atypical opioid agonists and MOR 133
Expression of the transcription factor REST at different stages of neuronal differentiation: contribution of PKC and WNT/-catenin signaling 132
Reactive oxygen species (ROS) generation is stimulated by opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation 132
Inhibition of Toll-like Receptor 4 (TLR4)-induced NF-kB activation by NOP is lost in human glioblastoma cells chronically exposed to LPS. 131
Investigation on MOR receptor activation by atypical mechanisms 129
Development and characterization of novel EphB1 receptor antagonists. 129
Bioluminescence resonance energy transfer (bret) to detect the interactions between kappa opioid receptor and nonvisual arrestins 127
Identification of a new, functional cross-talk between EphB1 receptor and mu opioid receptor 125
Biphasic modulation of mu-opoid receptor (MOR) transcription by nociceptin in neuroblastoma cells co-expressing MOR and NOP receptors 124
Development and characterization of Endomorphin-1 analogues as novel potential analgesic drugs. 124
Quantitative Systems Pharmacology and Biased Agonism at Opioid Receptors: A Potential Avenue for Improved Analgesics 121
Novel Antagonist targeting EphB1 receptor 118
Identification of a novel, functional cross-talk between EphB1 receptor and mu opioid receptor 117
Development and characterization of novel EphB1 receptor antagonists 116
Molecular Mechanisms Mediating Nociceptin/Orphanin FQ Receptor Signaling, Desensitization and Internalization. 115
Identification of a novel, functional cross-talk between EphB1 receptor and mu opioid receptor. 114
Protein Kinase C-dependent up-regulation of human mu-opioid receptor gene (OPRM1) transcription is negatively influenced by the transcription factor REST 113
Trypoids, a novel group of mu-opioid receptor-selective di- and tri-peptides: design and characterization of novel analgesics 113
Opioid activity profiles of peptides containing overlapping portions of CJ-15,208 and CycloEM, and identification of the bioactive conformations 111
Ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist, involves eosinophil's apoptosis. 111
Synthesis of tripeptides containing D-Trp substituted at indole ring, and assessment of MOR affinity and in vivo central antinociception. 108
The ocular antiallergic action of mapracorat, a novel selective glucocorticoid receptor agonist, involves eosinophils and mast cells: evidence from human cells in vitro and an animal model 108
PKC regulates MOR transcriptional activity: role of the proximal region of the promoter 104
TRYptophan-COntaining Non-Cationizable Opioid PeptideS (TRYCONCOPS): A new paradigm for opioid peptides 104
Neuron-Glia cross-talk: pharmacological and biotechnological strategies to identify novel therapeutic targets for neuropatic pain 103
Pro-inflammatory stimuli increase mu-opioid receptor (MOR) number on cell surface of human glioblastoma cells but hamper opioid agonist-induced intracellular signaling. G-protein-coupled-receptors: from structural insights to functional mechanisms 103
Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late phase experimental ocular allergy 102
Genomic and non-genomic effects of anabolic steroids on opioid receptor gene expression in neuronal cells 101
TNF-alpha-induced MOR up-regulation in human glioblastoma cells is coupled to a loss of MOR-activated signalling to intracellular effectors 100
Renilla luciferase reporter assay to study 3′-utr-driven posttranscriptional regulation of oprm1 100
PKC modulation of mu-opioid receptor gene (OPRM1) transcription is influenced by the transcription factor REST 99
At the cross-roads between immune system and nervous system: expression and intracellular signalling of opioid and opioid-related receptors in human glial cells exposed to pro-inflammatory stimuli. 99
Insulin-like Growth Factor I (IGF-I) induces human mu opioid receptor (MOR) expression in differentiated neurons: role of transcription factors REST and STAT3 98
Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model 97
Insulin-like Growth Factor I (IGF-I) modulates hMOR transcription in neuronal cells: role of STAT3 96
null 93
Endomorphin-1 analogues as novel and highly selective MOPr agonists: design and characterization of innovative analgesic drugs 93
Targeting α4β1 integrin: from cyclic to linear ligands, effects of chemical modifications 90
Expression of the Cannabinoid Receptor type I in T-cells and its regulation by cannabinoids and IL-4 86
Regulation of mu-opioid receptor by gene transcription 83
Functional cross-talk between TLR4 and NOPr in human glial cells. 79
Mechanisms of morphine-induced suppression of T-cell signaling. 78
The quest for more effective analgesics with reduced abuse liability and fewer adverse effects: Promises, pitfalls, and future perspectives of biased agonists at opioid receptors 71
null 54
Computational Pharmacodynamic Analysis of Cyclopeptides Derived from c[Trp-Phe-D-Pro-Phe] (CJ-15,208), an Unusual Class of Mixed μ/k-Opioid Receptor Ligands Lacking the Traditional Pharmacophores 49
Totale 12.490
Categoria #
all - tutte 34.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.308 0 80 66 61 147 73 64 144 63 88 213 309
2022/20231.667 177 310 75 184 148 128 81 85 282 40 96 61
2023/2024513 37 74 23 35 34 133 40 29 28 23 35 22
2024/20251.857 57 294 190 96 402 107 184 59 7 75 48 338
2025/20263.574 184 264 306 286 428 208 399 185 715 299 192 108
2026/2027159 121 38 0 0 0 0 0 0 0 0 0 0
Totale 12.490